Moon-Chang Baek Selected Research

Neoplasms (Cancer)

2/2024	Cathepsin D promotes polarization of tumor-associated macrophages and metastasis through TGFBI-CCL20 signaling.
1/2024	Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications.
1/2023	GDNF family receptor alpha-like antagonist antibody alleviates chemotherapy-induced cachexia in melanoma-bearing mice.
1/2023	Engineered CD8+ T cell-derived extracellular vesicles induce enhanced anti-cancer efficacy and targeting to lung cancer cells.
12/2022	Reprogramming of T cell-derived small extracellular vesicles using IL2 surface engineering induces potent anti-cancer effects through miRNA delivery.
10/2022	Novel antitumor therapeutic strategy using CD4+ T cell-derived extracellular vesicles.
8/2022	Temsirolimus Enhances Anti-Cancer Immunity by Inducing Autophagy-Mediated Degradation of the Secretion of Small Extracellular Vesicle PD-L1.
1/2022	Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1.
1/2022	Immune cell-derived small extracellular vesicles in cancer treatment.
1/2022	Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD-L1.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moon-Chang Baek Research Topics

Disease

23	Neoplasms (Cancer) 02/2024 - 10/2009
10	Breast Neoplasms (Breast Cancer) 08/2022 - 10/2012
10	Inflammation (Inflammations) 01/2022 - 01/2012
8	Sepsis (Septicemia) 06/2021 - 04/2016
6	Lung Injury 02/2020 - 04/2016
6	Hypothermia 01/2019 - 08/2012
5	Anaphylaxis (Anaphylactic Shock) 01/2019 - 01/2017
3	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2016
3	Colitis 10/2023 - 01/2022
3	Brain Injuries (Brain Injury) 10/2023 - 08/2012
3	Melanoma (Melanoma, Malignant) 01/2023 - 04/2016
3	Insulin Resistance 12/2015 - 07/2013
3	Type 2 Diabetes Mellitus (MODY) 06/2015 - 09/2012
2	Endotoxemia 10/2023 - 08/2021
2	Body Weight (Weight, Body) 01/2023 - 07/2013
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2019
2	Bone Resorption 08/2021 - 02/2021
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2016
2	Infections 02/2020 - 01/2003
2	Colonic Neoplasms (Colon Cancer) 11/2018 - 09/2014
2	Septic Shock (Toxic Shock Syndrome) 01/2017 - 04/2016
2	Neuroinflammatory Diseases 09/2014 - 08/2012
2	Carcinoma (Carcinomatosis) 10/2012 - 10/2009
2	Virus Diseases (Viral Diseases) 06/2004 - 01/2003
1	Anorexia 01/2023
1	Cachexia 01/2023
1	Dysbiosis 08/2021
1	Bone Diseases (Bone Disease) 08/2021

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2010
11	Biomarkers (Surrogate Marker)IBA 12/2021 - 06/2011
7	CytokinesIBA 02/2024 - 01/2016
7	HMGB1 Protein (HMG1)IBA 06/2021 - 04/2016
6	Immunoglobulin E (IgE)IBA 01/2019 - 01/2016
5	OvalbuminIBA 01/2019 - 01/2017
4	B7-H1 AntigenIBA 12/2022 - 01/2022
4	Immune Checkpoint InhibitorsIBA 08/2022 - 01/2022
4	Peptides (Polypeptides)IBA 11/2021 - 12/2010
4	EnzymesIBA 06/2016 - 06/2004
3	Dextran SulfateIBA 10/2023 - 01/2022
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2012
3	Sulfisoxazole (Sulfafurazole)FDA Link 01/2022 - 09/2016
3	AntioxidantsIBA 01/2022 - 10/2019
3	Particulate MatterIBA 02/2020 - 01/2019
3	Histamine (Histamine Dihydrochloride)FDA Link 01/2019 - 01/2017
3	Interleukin-4 (Interleukin 4)IBA 01/2019 - 10/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 09/2012
3	MethylthiouracilIBA 01/2017 - 09/2015
3	ProteomeIBA 09/2014 - 08/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 03/2014 - 01/2012
2	ChemokinesIBA 02/2024 - 01/2016
2	Dextrans (Dextran)FDA Link 10/2023 - 09/2022
2	Ellagic AcidIBA 10/2023 - 08/2021
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2023 - 09/2022
2	AntibodiesIBA 01/2023 - 08/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2022 - 04/2013
2	Endothelin Receptors (Endothelin Receptor)IBA 01/2022 - 01/2019
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 11/2021 - 10/2017
2	Local Anti-Infective Agents (Antiseptics)IBA 06/2021 - 01/2019
2	biapenem (L 627)IBA 06/2021 - 02/2020
2	Mitogen-Activated Protein KinasesIBA 02/2021 - 03/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2021 - 03/2014
2	Peroxidase (Myeloperoxidase)IBA 02/2020 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 10/2019
2	Interleukin-6 (Interleukin 6)IBA 10/2019 - 12/2016
2	decursinIBA 01/2019 - 01/2019
2	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2018 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2017 - 01/2016
2	Antithyroid Agents (Antithyroid Drugs)IBA 12/2016 - 09/2015
2	Tumor Biomarkers (Tumor Markers)IBA 06/2016 - 01/2016
2	N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime (PUGNAC)IBA 12/2015 - 10/2013
2	Matrix Metalloproteinases (MMPs)IBA 09/2014 - 07/2010
2	Messenger RNA (mRNA)IBA 09/2014 - 10/2011
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2014 - 04/2013
2	XenobioticsIBA 03/2014 - 04/2013
2	Glucose (Dextrose)FDA LinkGeneric 07/2013 - 12/2011
2	Urea (Carbamide)FDA LinkGeneric 04/2013 - 01/2012
1	Chemokine CCL20IBA 02/2024
1	Cathepsin DIBA 02/2024
1	RNA (Ribonucleic Acid)IBA 02/2024
1	Drinking WaterIBA 10/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Cetuximab (Erbitux)FDA Link 01/2023
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2023
1	Growth Differentiation Factor 15IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 12/2022
1	Interleukin-2 (IL2)IBA 12/2022
1	temsirolimus FDA Link 08/2022
1	Atorvastatin (Lipitor)FDA Link 08/2022
1	formycin diphosphate (FDP)IBA 01/2022
1	macitentanIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	SulfonamidesIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022

Therapy/Procedure

10	Therapeutics 02/2024 - 09/2015
4	Immunotherapy 01/2024 - 09/2012
4	Drug Therapy (Chemotherapy) 01/2023 - 12/2010
4	Ligation 06/2021 - 01/2019
3	Punctures 06/2021 - 01/2019
3	Oral Administration 01/2019 - 01/2016
2	Induced Hypothermia 12/2012 - 08/2012